Ingrid Rapp
Directeur Général chez Labor Dr. Merk & Kollegen GmbH
Postes actifs de Ingrid Rapp
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Labor Dr. Merk & Kollegen GmbH
 Labor Dr. Merk & Kollegen GmbH BiotechnologyHealth Technology Part of C.H. Boehringer Sohn AG & Co. KG, Labor Dr. Merk & Kollegen GmbH is a German company that engages in research & development and manufacturing of vaccines and viral therapeutics. The company is based in Ochsenhausen, Germany. The CEO of the company is Ingrid Rapp. Labor Dr. Merk & Kollegen was acquired by Boehringer Ingelheim International GmbH on December 15, 2020. | Directeur Général | - | - |
Historique de carrière de Ingrid Rapp
Statistiques
Internationale
| Allemagne | 2 |
Opérationnelle
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Labor Dr. Merk & Kollegen GmbH
Labor Dr. Merk & Kollegen GmbH BiotechnologyHealth Technology Part of C.H. Boehringer Sohn AG & Co. KG, Labor Dr. Merk & Kollegen GmbH is a German company that engages in research & development and manufacturing of vaccines and viral therapeutics. The company is based in Ochsenhausen, Germany. The CEO of the company is Ingrid Rapp. Labor Dr. Merk & Kollegen was acquired by Boehringer Ingelheim International GmbH on December 15, 2020. | Health Technology |
- Bourse
- Insiders
- Ingrid Rapp
- Expérience
